Home

Market Capitalization of Natco Pharma Ltd

Image

Natco Pharma Ltd

NSE: NATCOPHARM

Market Cap

₹ 22492.62 crore

Last updated on: Jan 14, 2025

Key Highlights

  • The Market Cap of Natco Pharma Ltd is ₹ 22492 crore as of 14 Jan 25 .
  • The Latest Trading Price of Natco Pharma Ltd is ₹ 1229 as of 15 Jan 14:17 .
  • The Dividend Payouts of Natco Pharma Ltd changed from ₹ 1.25 on Feb 21, 2023 to ₹ 1.5 on Nov 27, 2024 . This represents a CAGR of 3.09% over 6 years.
Image

Natco Pharma Ltd

NSE: NATCOPHARM

Share Price

₹ 1229.6

-26.20 (-2.09%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251255.8
13 Jan 20251212.35
10 Jan 20251235.5
09 Jan 20251288.95
08 Jan 20251318.7
07 Jan 20251326.6
06 Jan 20251310.15
03 Jan 20251366.85
02 Jan 20251385.35
01 Jan 20251398.7

SWOT Analysis Of Natco Pharma Ltd

Strength

4

che

Weakness

3

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Natco Pharma Ltd

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Natco Pharma Ltd

No data available

No data available

Historical P/E Ratio of Natco Pharma Ltd

No data available

* All values are in %

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Natco Pharma Ltd

No data available

* All values are in

About Natco Pharma Ltd

  • Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.
  • It sells products in over 40 countries.
  • FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
  • Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.

Natco Pharma Ltd News Hub

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad

Read more

2024-09-04 00:00:00

Natco Pharma fixes record date for second interim dividend

Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The

Read more

2024-08-12 00:00:00

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2

Read more

2024-08-12 00:00:00

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30

Read more

2024-08-12 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Natco Pharma Ltd Market Cap

What is the market cap of Natco Pharma Ltd?

As of January 15, 2025, Natco Pharma Ltd has a market capitalization of ₹22492.62, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Natco Pharma Ltd's market capitalization?

Natco Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Natco Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Natco Pharma Ltd's market capitalization change?

Natco Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions